MAPT and Alzheimer disease: In the context of AD, GSK3, more exactly GSK3-β, has been proposed as a central mediator of pathogenesis and plays a leading role in the cascade of events that culminate in AD, such as the hyper-phosphorylation of tau, the increased production of Aβ, memory impairment, and neuroinflammation.